Inscripta is at the forefront of biomanufacturing innovation, leveraging advanced technologies such as Lean Bioengineering™ and GenoScaler™ to enhance the efficiency and cost-effectiveness of strain engineering. The Lean Bioengineering™ approach integrates Directed Evolution, CRISPR+, and Machine Learning, enabling faster timelines and increased success rates in developing biomanufactured products. GenoScaler™, a proprietary platform, revolutionizes the strain optimization process by identifying and recombining genetic edits to create strains with high commercial potential. This technology significantly accelerates the development cycle, achieving results in 2-4 weeks and offering a cost-effective solution that is 1,000 times cheaper than traditional methods.

The company’s recent acquisitions of Infinome Biosciences and Sestina Bio further bolster its capabilities in sustainable biomanufacturing. These acquisitions enhance Inscripta's technological portfolio, allowing for the rapid optimization of microbial strains and the generation of extensive biological data. By combining innovative strain design with genome editing technologies, Inscripta aims to reduce the time and costs associated with bringing new products to market. The company is committed to addressing diverse market needs across agriculture, pharmaceuticals, and personal care, ultimately contributing to a cleaner and more sustainable bioeconomy.

United States

Inscripta® is a life science technology company committed to creating a cleaner, healthier, and more sustainable world through biomanufacturing. A global leader in genome engineering, our innovations are designed to unlock the full potential of the bioeconomy. We are committed to the continued development of critical technologies that enable scientists to bolster and expand domestic biomanufacturing, and spur new, safe, and secure biotech innovations. Inscripta supports customers around the world from facilities in Pleasanton and Burlingame, California.
To learn more, visit Inscripta.com and follow @InscriptaInc.

Inscripta

Company Details